143 related articles for article (PubMed ID: 6943305)
1. Alteration of blood-CSF barrier by tumor invasion into the meninges.
Ushio Y; Shimizu K; Aragaki Y; Arita N; Hayakawa T; Mogami H
J Neurosurg; 1981 Sep; 55(3):445-9. PubMed ID: 6943305
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy with 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride and bleomycin in meningeal carcinomatosis in rats.
Shimizu K; Ushio Y; Hayakawa T; Mogami H
Cancer Res; 1980 Apr; 40(4):1341-3. PubMed ID: 6153573
[TBL] [Abstract][Full Text] [Related]
3. [Local blood flow and capillary permeability in the experimental meningeal carcinomatosis].
Yamada N; Yamada K; Ushio Y; Hayakawa T; Kato A; Mogami H
No To Shinkei; 1984 Mar; 36(3):221-6. PubMed ID: 6588976
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal ACNU against experimental leptomeningeal tumors.
Huang TY; Howng SL
Kaohsiung J Med Sci; 1997 Oct; 13(10):626-30. PubMed ID: 9385779
[TBL] [Abstract][Full Text] [Related]
5. [Intrathecal ACNU for the treatment of a meningeal gliomatosis model].
Yoshida T; Shimizu K; Mogami H; Egawa T; Sakamoto Y
Gan To Kagaku Ryoho; 1987 Jan; 14(1):84-90. PubMed ID: 3467657
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of intrathecal 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride in rats.
Huang TY; Arita N; Ushio Y; Hayakawa T; Yamada K
J Neurooncol; 1994; 19(3):245-50. PubMed ID: 7807175
[TBL] [Abstract][Full Text] [Related]
7. [Intrathecal ACNU against malignant leptomeningeal tumors--toxicity and therapeutic effect in experimental animals].
Nagatani M; Arita N; Ushio Y; Hayakawa T; Tzuu-Yuan H; Yoshimine T; Mori S; Mogami H
No To Shinkei; 1986 Nov; 38(11):1071-5. PubMed ID: 3468960
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal chemotherapy with ACNU in a meningeal gliomatosis rat model.
Yoshida TK; Shimizu K; Koulousakis A; Sturm V
J Neurosurg; 1992 Nov; 77(5):778-82. PubMed ID: 1403122
[TBL] [Abstract][Full Text] [Related]
9. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
Kooistra KL; Rodriguez M; Powis G
Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal ACNU--a new therapeutic approach against malignant leptomeningeal tumors.
Arita N; Ushio Y; Hayakawa T; Nagatani M; Huang TY; Izumoto S; Mogami H
J Neurooncol; 1988 Nov; 6(3):221-6. PubMed ID: 3225641
[TBL] [Abstract][Full Text] [Related]
11. [Distribution of ACNU in the rat brain after intracisternal injection--macroscopical autoradiographic study].
Huang TY; Arita N; Ushio Y; Hayakawa T; Nagatani M; Mogami H
No To Shinkei; 1987 Mar; 39(3):263-6. PubMed ID: 3472532
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal chemotherapy with ACNU for meningeal gliomatosis.
Yoshida TK; Beuls E; Shimizu K; Koulousakis A; Sturm V
Br J Cancer; 1992 Dec; 66(6):999-1004. PubMed ID: 1457369
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy for experimental subarachnoid dissemination model of brain tumor].
Yamashita T; Shinonaga M; Ishiwata Y; Nishimura S; Murai M; Kyuma Y; Kuwabara T
No Shinkei Geka; 1984 Jan; 12(1):47-53. PubMed ID: 6585681
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics of ACNU in cerebrospinal fluid].
Imagawa K; Kawasaki M; Toda I; Hayashi M; Asai A; Nomura T
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1543-8. PubMed ID: 6964049
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system toxicity and cerebrospinal fluid pharmacokinetics of intraventricular 3-[(4-amino-2-methyl-5-pyrimidinyl)ethyl]-1-(2-chloroethyl)-1-nitro soureas and other nitrosoureas in beagles.
Levin VA; Byrd D; Campbell J; Giannini DD; Borcich JK; Davis RL
Cancer Res; 1985 Aug; 45(8):3803-9. PubMed ID: 3860287
[TBL] [Abstract][Full Text] [Related]
16. Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosou rea hydrochloride.
Kochi M; Kuratsu J; Mihara Y; Takaki S; Seto H; Uemura S; Ushio Y
Neurosurgery; 1993 Nov; 33(5):817-23. PubMed ID: 8264878
[TBL] [Abstract][Full Text] [Related]
17. [Effect of ACNU against experimental brain tumor--immunohistochemical study using anti-BrdU monoclonal antibody].
Izumoto S; Arita N; Ushio Y; Hayakawa T; Yoshimine T; Tzuu-Yuan H; Nagatani M; Oku Y; Mogami H
No To Shinkei; 1988 Nov; 40(11):1095-9. PubMed ID: 3219244
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
Fujimoto S; Ogawa M; Hoshino A
Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770
[TBL] [Abstract][Full Text] [Related]
19. [Growth activity of meningeal carcinomatosis--immunohistochemical study using anti-BrdU monoclonal antibody].
Izumoto S; Arita N; Ushio Y; Hayakawa T; Yoshimine T; Huang TY; Kuroda R; Mogami H
No To Shinkei; 1988 Feb; 40(2):127-31. PubMed ID: 3370164
[TBL] [Abstract][Full Text] [Related]
20. ACNU, MTX and 5-FU penetration of rat brain tissue and tumors.
Huang TY; Arita N; Hayakawa T; Ushio Y
J Neurooncol; 1999; 45(1):9-17. PubMed ID: 10728905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
